PUBLISHER: The Business Research Company | PRODUCT CODE: 1763101
PUBLISHER: The Business Research Company | PRODUCT CODE: 1763101
Ticovac Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
TicoVac is a vaccine designed to protect against tick-borne encephalitis (TBE), a viral disease primarily transmitted through tick bites or, less frequently, through the consumption of unpasteurized dairy products from infected animals. TBE impacts the central nervous system and can cause severe neurological issues, such as meningitis and encephalitis. TicoVac works by stimulating the immune system to recognize and combat the tick-borne encephalitis virus (TBEV) if the body is exposed to it in the future.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary types of ticoVac formulations are inactivated vaccines and live attenuated vaccines. Tick-borne encephalitis is a viral infection transmitted by infected ticks that affects the central nervous system, potentially causing severe neurological complications. The vaccine is also used for preventing Japanese encephalitis and rabies encephalitis and is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The ticovac market research report is one of a series of new reports from The Business Research Company that provides ticovac market statistics, including ticovac industry global market size, regional shares, competitors with a ticovac market share, detailed ticovac market segments, market trends and opportunities, and any further data you may need to thrive in the ticovac industry. This ticovac market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ticovac market size is expected to see strong growth in the next few years. It will grow to $5,700 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing in outdoor workers, increasing healthcare expenditure, increasing focus on regional disease control, rising in health insurance coverage, rising incidence of tick-borne encephalitis (tbe) cases. Major trends in the forecast period include technological advancements in vaccine production, introduction of new tbe vaccines, collaborations between governments and pharmaceutical companies, advances in genetic research, advances in monitoring and post-vaccination care.
The rising prevalence of tick-borne diseases is expected to drive the growth of the ticovac market. Tick-borne diseases, which are transmitted through tick bites and caused by bacteria, viruses, or parasites, are increasing due to climate change, expanding tick habitats, greater human exposure, and improved diagnostic methods. Ticovac plays a crucial role in combating these diseases by providing active immunization against tick-borne encephalitis (TBE), a potentially severe viral infection. For example, in February 2024, the Centers for Disease Control and Prevention reported that the incidence of Lyme disease in the U.S. had risen by 68.8% compared to previous years, highlighting the growing burden of tick-borne diseases. This rise in incidence is expected to boost the demand for vaccines such as ticovac, driving market growth.
The increasing research and development (R&D) activities are key factor propelling the ticovac market. R&D efforts are aimed at creating new products, enhancing existing ones, and developing technologies to address emerging global health challenges. The focus on R&D in the pharmaceutical sector has led to innovations that improve vaccine formulations, including better efficacy and the ability to address emerging strains of tick-borne encephalitis. For example, in July 2024, the Department of Health and Social Care reported that the UK's pharmaceutical R&D sector spent $11.3 billion on research in 2022, emphasizing the increasing investment in R&D to address health threats like tick-borne diseases.
A significant trend in the ticovac market is the development of innovative vaccine formulations, such as suspension liquids, which offer a competitive edge. Suspension liquid vaccines are designed for intramuscular injection and are available in different dosages for both adults and children. In September 2024, Pfizer launched Ticovac in Japan, marking the first vaccine of its kind in the country for the prevention of tick-borne encephalitis. This new formulation is expected to enhance the vaccine's accessibility and effectiveness, further driving market growth.
Key player operating in the ticovac market is Pfizer Inc.
Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ticovac market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ticovac market consists of sales of pediatric vaccines, cardiovascular and metabolic products, anti-infective medications and rare disease medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ticovac Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ticovac market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ticovac ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ticovac market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines
- 2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Companies Mentioned: Pfizer Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Ticovac Market Characteristics
3. Ticovac Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
4. Ticovac Market Trends And Strategies
5. Ticovac Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Ticovac Growth Analysis And Strategic Analysis Framework
- 6.1. Global Ticovac PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Ticovac Market Growth Rate Analysis
- 6.4. Global Ticovac Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 6.5. Global Ticovac Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 6.6. Global Ticovac Total Addressable Market (TAM)
7. Global Ticovac Market Pricing Analysis & Forecasts
8. Ticovac Market Segmentation
- 8.1. Global Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inactivated Vaccines
- Live Attenuated Vaccines
- 8.2. Global Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tick-Borne Encephalitis
- Japanese Encephalitis
- Rabies Encephalitis
- 8.3. Global Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
9. Global Ticovac Market Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
10. Ticovac Market Regional And Country Analysis
- 10.1. Global Ticovac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. Global Ticovac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Ticovac Market
- 11.1. Asia-Pacific Ticovac Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Asia-Pacific Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Asia-Pacific Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Ticovac Market
- 12.1. China Ticovac Market Overview
- 12.2. China Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.3. China Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.4. China Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Ticovac Market
- 13.1. India Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. India Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. India Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Ticovac Market
- 14.1. Japan Ticovac Market Overview
- 14.2. Japan Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. Japan Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. Japan Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Ticovac Market
- 15.1. Australia Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.2. Australia Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Australia Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Ticovac Market
- 16.1. South Korea Ticovac Market Overview
- 16.2. South Korea Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. South Korea Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.4. South Korea Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Ticovac Market
- 17.1. Western Europe Ticovac Market Overview
- 17.2. Western Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Western Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.4. Western Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Ticovac Market
- 18.1. UK Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. UK Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. UK Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Ticovac Market
- 19.1. Germany Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Germany Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Germany Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Ticovac Market
- 20.1. France Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. France Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. France Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ticovac Market
- 21.1. Eastern Europe Ticovac Market Overview
- 21.2. Eastern Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Ticovac Market
- 22.1. North America Ticovac Market Overview
- 22.2. North America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. North America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.4. North America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Ticovac Market
- 23.1. USA Ticovac Market Overview
- 23.2. USA Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. USA Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. USA Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Ticovac Market
- 24.1. Canada Ticovac Market Overview
- 24.2. Canada Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. Canada Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. Canada Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Ticovac Market
- 25.1. South America Ticovac Market Overview
- 25.2. South America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. South America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. South America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Ticovac Market
- 26.1. Middle East Ticovac Market Overview
- 26.2. Middle East Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. Middle East Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. Middle East Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Ticovac Market
- 27.1. Africa Ticovac Market Overview
- 27.2. Africa Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Africa Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.4. Africa Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Ticovac Market Competitive Landscape And Company Profiles
- 28.1. Ticovac Market Competitive Landscape
- 28.2. Ticovac Market Company Profiles
- 28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Ticovac Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
30. Global Ticovac Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Ticovac Market
32. Recent Developments In The Ticovac Market
33. Ticovac Market High Potential Countries, Segments and Strategies
- 33.1 Ticovac Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Ticovac Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Ticovac Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
